- Ancestry Steps Up 23andMe Rivalry With DNA Health TestsConsumer genomics firm Ancestry will begin selling DNA health test kits, setting up a showdown with 23andMe.
- Could Lowering Drug Prices Hamper Drug Innovation?—Brainstorm HealthHappy Monday, readers. The Congressional Budget Office (CBO)—that scorekeeper of how federal policies will affect business, the government, and the public at large—has a preliminary report out on how House Speaker Nancy Pelosi’s proposed drug pricing legislation may affect the federal budget, public health programs, and the drug industry at large. It’s a lot to […]
- California Wants to Prevent HIV By Making Treatments Prescription-FreeA new California law would allow pharmacies to sell HIV prevention drugs to people who don't have a prescription.
- What We Should Consider on World Mental Health Day: Brainstorm HealthGood afternoon, readers. October 10 is World Mental Health Day—and Fortune has a special guest piece by Arianna Huffington (media titan, CEO of the wellness group Thrive Global, and one of our Brainstorm Health conference co-chairs) on the importance of shifting the theoretical conversations surrounding mental health to actual, well, action. How, exactly, can we […]
- California Wants to Prevent HIV By Making Treatments Prescription-FreeA new California law would allow pharmacies to sell HIV prevention drugs to people who don't have a prescription.
- This Startup Raised $3 Million to Staff Hospitals With RobotsDigital health firm Diligent Robotics has raised $3 million in a funding round for its robotic hospital assistant, Moxi.
- How China Is Transforming the Biotech Industry: Brainstorm HealthHello and happy Monday, readers. Fortune sat down with Brad Loncar, a biotech investor who specializes in cancer immunotherapy, at our offices last week. Loncar runs both a U.S.-based index fund for cancer drug companies and, more recently, launched another one focused on China. It was a fascinating conversation that covered everything from the U.S. […]
Skip to Content